Clinical Trial Update: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating empagliflozin for effects on peritoneal and kidney function in patients with end-stage renal disease on dialysis. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Yale University | Conditions: End Stage Renal Disease on Dialysis | Phase 4 | Status: RECRUITING